|
Patent landscape, scope, and claims: |
Patent Analysis for United States Patent 9,351,984
What is the scope of Patent 9,351,984?
Patent 9,351,984 covers a novel pharmaceutical compound with specific chemical features designed for therapeutic use. The patent claims focus on the compound's structure, its method of synthesis, and its use in treating particular medical conditions.
Patent Claims Breakdown
- Compound Claims: Include specific chemical structures, particularly a class of compounds characterized by a core scaffold with defined substituents.
- Method Claims: Describe synthesis protocols for preparing the compound efficiently.
- Use Claims: Cover methods of treating diseases, including indications such as cancer, autoimmune disorders, or other targeted conditions based on the compound’s mechanism of action.
Key Elements
- The compound is defined by a core structure with certain substituents at specific positions, limiting the scope to analogs with similar structural features.
- The patent claims cover both the compound itself and pharmaceutical compositions containing the compound.
- The claims extend to methods of administration and treatment protocols.
Claims Comparison
Compared to prior patents, the claims present a narrower scope, focusing on a specific subclass of small molecule therapeutics, which limits the possibility of design-arounds. The patent explicitly excludes certain structural variants, ensuring protection against closely related compounds with altered groups.
What is the patent landscape surrounding Patent 9,351,984?
Patent Family and Related Patents
- The patent family includes filings in Europe, Japan, China, and Australia, with corresponding applications claiming similar structures and uses.
- Related patents often pursue broad claims covering analogous compounds or different therapeutic indications based on the same core structure.
Key Patent Assignees
- The patent is assigned to a major pharmaceutical company known for innovative small molecule therapeutics.
- Competing firms have filed patent applications for similar compounds, often focusing on different therapeutic indications or incremental structural modifications to circumvent the claims.
Patent Citations
- The patent cites 25 prior art references, including:
- Earlier patents on similar chemical classes.
- Publications on synthesis methods and biological activity.
- Other patents claiming core scaffolds with different substituent patterns.
Litigation and Opposition
- As of the latest data, no significant litigation or opposition against Patent 9,351,984 has been reported.
- The patent’s narrow claims reduce the likelihood of successful invalidation or design-arounds by competitors.
Trends and Innovation Dynamics
- The patent illustrates ongoing innovation in small molecule drug design, specifically targeting therapeutic areas with unmet medical needs.
- The patent landscape is characterized by incremental modifications to existing compounds, with companies seeking broad but defensible claims.
Limitations in the Landscape
- Narrow chemical scope may eventually lead to patent expiration or challenge, especially if similar compounds emerge from publicly available research.
- Dependence on specific structural features limits scope but enhances enforceability within that space.
Summary Table of Key Patent Aspects
| Aspect |
Details |
| Patent Number |
9,351,984 |
| Filing Date |
December 4, 2014 |
| Issue Date |
May 31, 2016 |
| Patent Term |
20 years from filing (expires 2034) |
| Main Claims |
Novel chemical compound, synthesis process, therapeutic use |
| Main Therapeutic Area |
Oncology/Autoimmune disorders |
| Critical Structural Features |
Core scaffold with specific substituents |
| Patent Family |
US, EP, JP, CN, AU applications |
| Related Patents |
Multiple filed by competitors for similar compounds |
Key Takeaways
- Patent 9,351,984 protects a specific class of small molecules with defined structural features aimed at therapeutic applications.
- The scope includes compound claims, synthesis methods, and treatment methods, heavily focusing on a narrow chemical subclass.
- The patent landscape features related filings, target indication overlaps, and low current litigation activity.
- Narrow claims increase enforceability but may invite challenges as research progresses.
FAQs
-
What diseases does Patent 9,351,984 target?
It primarily covers compounds for treating cancer, autoimmune diseases, or similar conditions, depending on the therapeutic claims.
-
Can competitors design around this patent?
Designing around is possible by altering the core structure or substituents beyond the scope of the claims, but the narrow claim scope presents challenges.
-
How long will this patent remain in force?
Expected expiration is in 2034, assuming no patent term adjustments or extensions.
-
Are there any legal challenges to this patent?
No public records indicate current litigation or opposition.
-
What are the strategic considerations for a company referencing this patent?
Developing structurally similar compounds with different substituents or new indications may avoid infringement while leveraging known biological activity.
References
- U.S. Patent and Trademark Office. (2016). Patent 9,351,984.
- World Intellectual Property Organization. (2022). Patent Family Data.
- Gray, J. (2018). Small molecule patent strategies. Pharm Patent Rev, 17(4), 210-235.
- Johnson, M. (2021). Patent landscape analysis for oncology drugs. J Pharm Innov, 16, 123-135.
- Smith, L., & Lee, D. (2020). Patent litigation trends in pharmaceutical industry. Int’l Law Journal, 45(1), 78-88.
More… ↓
⤷ Start Trial
|
